BMY - Bristol-Myers Squibb Co

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Bristol-Myers Squibb raises 2025 revenue guidance by $700M as new launches and partnerships accelerate growth trajectory
• Bristol Myers in charts: Q2 revenue from Eliquis, Opdivo, Yervoy, Orencia rises Y/Y; Sprycel and Pomalyst/ Imnovid falls
• Bristol-Myers delivers double beat and raises full-year sales forecast
• Earnings Snapshot: Bristol-Myers tops Q2 estimates, FY outlook beats expectations
• Bristol-Myers Squibb Company Non-GAAP EPS of $1.46 beats by $0.36, revenue of $12.27B beats by $890M
• What to expect from Bristol-Myers Squibb's Q2 earnings?
• FDA vaccines head, chief medical officer Vinay Prasad departs agency
• Bristol Myers, Bain Capital form a new biopharmaceutical company
• Bristol Myers Squibb taps Cristian Massacesi as CMO
• Former biotech exec George Tidmarsh to lead key FDA drug center
• Bristol's Sotyktu to be reviewed by FDA for expanded label
• Bristol Myers fails in late-stage trial for Merck-partnered anemia therapy in blood cancer
• Bristol-Myers and Pfizer to offer 40% discount on blockbuster blood thinner Eliquis
• Trump eyes drug, chip tariffs by month-end
• FDA mulls faster drug reviews in exchange for lower prices in U.S.- Bloomberg
• FDA publishes more than 200 rejection letters in a bid to improve transparency
• Trump mulls 200% tariff on pharmaceuticals
• Prime Medicine soars as Jones sees it as an acquisition target
• Leaked memo reportedly shows biotech lobby group’s opposition to RFK Jr.
• US judge halts Trump administration move to layoff HHS employees